title: Development of a Chip/Chip/SRM platform using digital chip isoelectric focusing and LC-Chip mass spectrometry for enrichment and quantitation of low abundance protein biomarkers in human plasma.
abstract: Protein biomarkers are critical for diagnosis, prognosis, and treatment of disease. The transition from protein biomarker discovery to verification can be a rate limiting step in clinical development of new diagnostics. Liquid chromatography-selected reaction monitoring mass spectrometry (LC-SRM MS) is becoming an important tool for biomarker verification studies in highly complex biological samples. Analyte enrichment or sample fractionation is often necessary to reduce sample complexity and improve sensitivity of SRM for quantitation of clinically relevant biomarker candidates present at the low ng/mL range in blood. In this paper, we describe an alternative method for sample preparation for LC-SRM MS, which does not rely on availability of antibodies. This new platform is based on selective enrichment of proteotypic peptides from complex biological peptide mixtures via isoelectric focusing (IEF) on a digital ProteomeChip (dPC) for SRM quantitation using a triple quadrupole (QQQ) instrument with an LC-Chip (Chip/Chip/SRM). To demonstrate the value of this approach, the optimization of the Chip/Chip/SRM platform was performed using prostate specific antigen (PSA) added to female plasma as a model system. The combination of immunodepletion of albumin and IgG with peptide fractionation on the dPC, followed by SRM analysis, resulted in a limit of quantitation of PSA added to female plasma at the level of ∼1-2.5 ng/mL with a CV of ∼13%. The optimized platform was applied to measure levels of PSA in plasma of a small cohort of male patients with prostate cancer (PCa) and healthy matched controls with concentrations ranging from 1.5 to 25 ng/mL. A good correlation (r(2) = 0.9459) was observed between standard clinical ELISA tests and the SRM-based assay. Our data demonstrate that the combination of IEF on the dPC and SRM (Chip/Chip/SRM) can be successfully applied for verification of low abundance protein biomarkers in complex samples.
authors.affiliation: Barnett Institute of Chemical and Biological Analysis and Department of Chemistry and Chemical Biology, Northeastern University, 360 Huntington Avenue, Boston, Massachusetts 02115, United States.
authors.forename: Agnes
authors.initials: A
authors.lastname: Rafalko
authors.forename: Shujia
authors.initials: S
authors.lastname: Dai
authors.forename: William S
authors.initials: WS
authors.lastname: Hancock
authors.forename: Barry L
authors.initials: BL
authors.lastname: Karger
authors.forename: Marina
authors.initials: M
authors.lastname: Hincapie
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D015415:Biomarkers / Q000097:blood; D001798:Blood Proteins / Q000032:analysis* / Q000302:isolation & purification; D002417:Cattle; D002853:Chromatography, Liquid / Q000295:instrumentation* / Q000379:methods; D005260:Female; D006801:Humans; D007163:Immunosorbent Techniques; D007525:Isoelectric Focusing / Q000295:instrumentation* / Q000379:methods; D057230:Limit of Detection; D016014:Linear Models; D008297:Male; D013058:Mass Spectrometry / Q000295:instrumentation* / Q000379:methods; D008969:Molecular Sequence Data; D010446:Peptide Fragments / Q000032:analysis; D017430:Prostate-Specific Antigen / Q000032:analysis / Q000302:isolation & purification; D040081:Protein Array Analysis / Q000295:instrumentation*; D040901:Proteomics / Q000295:instrumentation / Q000379:methods; D015203:Reproducibility of Results; D014357:Trypsin / Q000737:chemistry
chemical_list: D015415:Biomarkers; D001798:Blood Proteins; D010446:Peptide Fragments; D014357:Trypsin; D017430:Prostate-Specific Antigen
references.citation: Mol Cell Proteomics. 2002 Nov;1(11):845-67
references.pmid: 12488461
references.citation: Anal Biochem. 2007 Mar 1;362(1):44-54
references.pmid: 17241609
references.citation: BMC Bioinformatics. 2007 Nov 01;8 Suppl 7:S23
references.pmid: 18047723
references.citation: Nat Biotechnol. 2009 Jul;27(7):633-41
references.pmid: 19561596
references.citation: Mol Cell Proteomics. 2006 Apr;5(4):573-88
references.pmid: 16332733
references.citation: J Proteome Res. 2004 Mar-Apr;3(2):235-44
references.pmid: 15113099
references.citation: Bioinformatics. 2008 Jul 1;24(13):1503-9
references.pmid: 18453551
references.citation: Anal Chem. 2009 Nov 15;81(22):9343-52
references.pmid: 19839594
references.citation: J Pharm Biomed Anal. 2004 Mar 10;34(5):851-60
references.pmid: 15019019
references.citation: Mol Cell Proteomics. 2011 Feb;10(2):M000062-MCP201
references.pmid: 20410378
references.citation: Curr Opin Chem Biol. 2009 Dec;13(5-6):518-25
references.pmid: 19818677
references.citation: Mol Cell Proteomics. 2008 Oct;7(10):1974-82
references.pmid: 18388126
references.citation: J Proteome Res. 2011 Jan 7;10(1):5-16
references.pmid: 21142170
references.citation: Mol Oncol. 2009 Feb;3(1):33-44
references.pmid: 19383365
references.citation: Electrophoresis. 2002 Sep;23(18):3143-8
references.pmid: 12298086
references.citation: J Pharm Biomed Anal. 2004 Jun 29;35(4):895-904
references.pmid: 15193734
references.citation: Mol Cell Proteomics. 2006 Oct;5(10):1968-74
references.pmid: 16849286
references.citation: Anal Chem. 2011 Jan 1;83(1):240-5
references.pmid: 21141837
references.citation: Clin Chem. 2010 Feb;56(2):281-90
references.pmid: 20022981
references.citation: Anal Chem. 2011 Jun 15;83(12):4845-54
references.pmid: 21513341
references.citation: Curr Opin Chem Biol. 2002 Feb;6(1):46-50
references.pmid: 11827822
references.citation: Proteomics. 2005 Jan;5(1):24-34
references.pmid: 15672457
references.citation: Mol Cell Proteomics. 2009 May;8(5):1006-15
references.pmid: 19068476
references.citation: J Biol Chem. 2010 Mar 5;285(10):7197-207
references.pmid: 20056612
references.citation: Mol Syst Biol. 2008;4:222
references.pmid: 18854821
references.citation: Nat Biotechnol. 2009 Feb;27(2):190-8
references.pmid: 19169245
references.citation: J Proteome Res. 2009 Feb;8(2):1085-90
references.pmid: 19196186
references.citation: Nat Biotechnol. 2007 Jan;25(1):125-31
references.pmid: 17195840
references.citation: Anal Chem. 2010 Jan 1;82(1):115-20
references.pmid: 19957969
references.citation: Mol Cell Proteomics. 2009 Aug;8(8):1860-77
references.pmid: 19411661
references.citation: Anal Chem. 2005 Oct 15;77(20):6549-56
references.pmid: 16223239
references.citation: J Proteome Res. 2004 May-Jun;3(3):644-52
references.pmid: 15253448
references.citation: Anal Chem. 2004 Apr 1;76(7):2040-5
references.pmid: 15053669
references.citation: J Proteome Res. 2008 Feb;7(2):640-7
references.pmid: 18186600
references.citation: Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9390-5
references.pmid: 10920198
references.citation: J Proteome Res. 2005 Nov-Dec;4(6):2273-82
references.pmid: 16335976
references.citation: J Biomol Tech. 2005 Sep;16(3):181-9
references.pmid: 16461941
references.citation: Electrophoresis. 2004 Jan;25(1):128-33
references.pmid: 14730577
references.citation: J Proteome Res. 2004 Nov-Dec;3(6):1234-42
references.pmid: 15595733
references.citation: Clin Chem. 2009 Jun;55(6):1108-17
references.pmid: 19372185
references.citation: Anal Chem. 2004 Aug 15;76(16):4811-24
references.pmid: 15307793
references.citation: Mol Cell Proteomics. 2005 Oct;4(10):1441-4
references.pmid: 16020426
references.citation: J Pharm Biomed Anal. 2005 Mar 9;37(3):423-8
references.pmid: 15740899
references.citation: Proteomics. 2004 Sep;4(9):2533-40
references.pmid: 15352227
references.citation: Anal Biochem. 2007 Oct 1;369(1):18-26
references.pmid: 17692277
references.citation: Proteomics Clin Appl. 2007 Jul;1(7):661-71
references.pmid: 21136721
references.citation: Mol Cell Proteomics. 2007 Dec;6(12):2212-29
references.pmid: 17939991
references.citation: Mol Cell Proteomics. 2009 Oct;8(10):2339-49
references.pmid: 19596694
references.citation: Bioinformatics. 2006 Jul 15;22(14):e481-8
references.pmid: 16873510
references.citation: EMBO Rep. 2008 May;9(5):429-34
references.pmid: 18451766